Acute Kidney Injury Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

Acute Kidney Injury Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight DelveInsight's 'Acute Kidney Injury Pipeline ...
Medscape

Cefazolin Noninferior to Antistaphylococcal Penicillins for Methicillin-Susceptible Staphylococcus aureus Bacteremia

Cefazolin is noninferior to antistaphylococcal penicillins for methicillin-susceptible Staphylococcus aureus bacteremia and ...

Mission Therapeutics strikes deal worth up to $292 million for Dimerix Ltd to develop Acute Kidney Injury asset MTX652, sharpens focus on its CNS pipeline

Mission Therapeutics has divested MTX652, a Phase 2-ready selective USP30 inhibitor for Acute Kidney Injury (AKI), to ...
PharmaTimes

Mission Therapeutics divests MTX652 to Dimerix in deal worth up to $292 million

Mission Therapeutics has agreed to divest its phase 2‑ready acute kidney injury candidate MTX652 to Australian renal ...
MedPage Today on MSN

AI-triggered nephrology consult fails to prevent acute kidney injury in trial

Increases in serum creatinine similar to patients who received usual care ...
Fierce Biotech

Dimerix snaps up Mission’s stalled, phase 2-ready kidney disease candidate in $292M deal

Dimerix has bought an acute kidney injury (AKI) drug from Mission Therapeutics, paying (PDF) $5 million upfront and ...
Morning Overview on MSN

A common blood-pressure pill mixed with a routine antibiotic can trigger kidney injury

Patients who take a calcium-channel blocker for high blood pressure and then receive a prescription for clarithromycin, one ...

5 new Rajasthan mothers' euthanasia plea puts spotlight on postpartum kidney injury: Doctor explains symptoms, causes and prevention

Five women in Rajasthan seeking help after alleged postpartum kidney failure have drawn attention to postpartum acute kidney ...

Dimerix Limited: Dimerix Expands Pipeline With Acquisition Of Phase 2 Ready Asset For Acute Kidney Injury

Highlights Dimerix acquires Phase 2-ready asset, DMX-652 - with potential for rapid advancement into a Phase 2 clinical study under an open US Investigational New ...